To confirm whether METTL1 and WDR4 expression could correlate with advanced tumour status, we measured PI3K pathway activity by phosphorylation status of S6K, which altered in in approximately 70% of patients with advanced PCa [47]. Here, RPS6KB1 is linked to neoplasm.